Valuation Tonix Pharmaceuticals Nasdaq

Stocks

End-of-day quote Nasdaq 2024-02-05			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

08-10	Tonix Pharmaceuticals Holding Corp., Q2 2026 Earnings Call, Aug 10, 2026
08-10	Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	177.4	22.42	23.62	61.64	193.6	205.3	-	-
Change	-	-87.36%	5.35%	160.94%	214.02%	6.07%	-	-
Enterprise Value (EV)	177.4	22.42	23.62	61.64	193.6	205.3	205.3	205.3
Change	-	-87.36%	5.35%	160.94%	214.02%	6.07%	0%	0%
P/E	-1.38x	-0.12x	-0.06x	-0.19x	-1.07x	-1.23x	-1.94x	7.17x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0x	0x	0x	0.1x	-0x
Capitalization / Revenue	-	-	3.04x	6.11x	14.8x	4.13x	1.77x	1x
EV / Revenue	-	-	0x	0x	0x	4.13x	1.77x	1x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-1.17x	-1.34x	-2.18x
EV / FCF	-	-	-	-	-	-1.05x	-1x	-1.28x
FCF Yield	-	-	-	-	-	-95%	-99.9%	-77.9%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-166,400	-65,400	-21,920	-176.6	-14.57	-9.713	-6.157	1.67
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	7.768	10.09	13.11	49.73	116.1	204.9
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-92.31	-112.1	-118.4	-136.7	-125.7	-175.7	-153.3	-94.25
Net income ¹	-92.29	-116.9	-116.7	-130	-124	-167.9	-152.8	-80.17
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	228,928.00	7,796.00	1,289.60	32.98	15.62	11.97	11.97	11.97
Nbr of stocks (in thousands)	0.78	2.88	18.3	1,869	12,392	17,151	-	-
Announcement Date	3/14/22	3/13/23	4/1/24	3/18/25	3/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.6x	12.64x	25.73x	0.57%	1,088B
JOHNSON & JOHNSON	29.02x	-	-	2.06%	629B
ABBVIE INC.	31.76x	7.4x	15.37x	2.76%	440B
ROCHE HOLDING AG	20.37x	4.83x	11.97x	2.73%	359B
NOVARTIS AG	21.72x	5.63x	14.03x	2.85%	291B
ASTRAZENECA PLC	20.24x	4.18x	11.87x	2.1%	245B
AMGEN INC.	26.11x	6.86x	12.2x	2.42%	225B
NOVO NORDISK A/S	13.56x	4.86x	10.12x	3.76%	204B
GILEAD SCIENCES, INC.	-42.19x	6.04x	34.06x	2.43%	168B
Average	17.24x	6.55x	16.92x	2.41%	405.47B
Weighted average by Cap.	24.66x	8.26x	18.73x	1.97%